Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus Dostarlimab in first line advanced/metastatic setting: DOMENICA STUDY - CONVERIS Research Information System by Thomson Reuters:

Go to Header Go to Navigation Go to Content Go to Footer

Title: Randomized phase III trial in MMR deficient endometrial cancer patients comparing
chemotherapy alone versus Dostarlimab in first line advanced/metastatic setting:
DOMENICA STUDY

Funder
ARCAGY-GINECO

Principal Investigator

Canham, Joanna

Project Details

Net value award figure for Cardiff University: £686,399.00

Start date: 27/03/2023

End date: 26/03/2030

Our policy towards the use of cookies